Professional Overview
Rudi Gomez is a seasoned professional currently serving as PRICING & HEOR at Novartis, located in East Hanover, New Jersey, United States. His key expertise areas include Health Economics & Outcomes Research (HEOR), pricing, and commercial strategy, with a strong industry focus on pharmaceuticals and healthcare.
Experience Summary
Current Role
As PRICING & HEOR at Novartis, Rudi is responsible for developing and implementing pricing strategies, conducting health economics and outcomes research, and collaborating with cross-functional teams to drive business growth. Although specific achievements in this role are not detailed, his experience in the field suggests a significant impact on the company's commercial success.
Career Progression
Rudi's career trajectory showcases progressive growth and diverse experience in the healthcare industry. Notable previous roles include:
- Commercial Director Nordics | Cell&Gene | Oncology Unit at Novartis
- Cell Therapy Network Manager | Cell&Gene | Oncology Unit at Novartis
- Health Economics & Outcomes Research (HEOR) at Sanofi
- Innovation Healthcare Consultant at Flowlab
- Strategic Healthcare Consultant at athenea solutions
These roles demonstrate his ability to adapt, lead, and contribute to various aspects of the healthcare and pharmaceutical sectors.
Areas of Expertise
Rudi's expertise encompasses:
- Health Economics and Outcomes Research (HEOR)
- Pricing and commercial strategy
- Pharmaceutical and healthcare industry knowledge
- Leadership and management
- Consultation and collaboration
Professional Impact
Although specific details on notable projects or initiatives are not provided, Rudi's extensive experience and the variety of roles he has held indicate a significant professional impact. His contributions to the healthcare and pharmaceutical industries are likely substantial, given his specialization in HEOR and pricing.
Conclusion
Rudi Gomez's professional trajectory is marked by steady growth, diversified experience, and a strong focus on the healthcare and pharmaceutical sectors. Currently, as PRICING & HEOR at Novartis, he leverages his expertise to drive strategic pricing and HEOR initiatives. With a value proposition rooted in his ability to navigate complex healthcare economics and commercial strategies, Rudi is positioned to continue making significant contributions to the industry.
